Major Histocompatibility Complex Class I Matching is Necessary but not Sufficient for Tolerance Induction to Vascularized Composite Allografts After Donor Hematopoietic Cell Transplantation. [PDF]
Manell E +19 more
europepmc +1 more source
Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation. [PDF]
Hobo W +17 more
europepmc +1 more source
Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease. [PDF]
Hasegawa Y, Teshima T, Hashimoto D.
europepmc +1 more source
HLA incompatibility mitigation strategies in off-the-shelf cancer immunotherapies: clinical implications and a practical framework for strategy selection and combination. [PDF]
Das R, Askar M.
europepmc +1 more source
Selection and Characterisation of Minor Histocompatibility Antigen-Specific Regulatory T Cells in Fully HLA-Matched Setting for GVHD Therapy. [PDF]
Pacini CP +5 more
europepmc +1 more source
Mixed Lymphocyte Reaction: Functional Immune Profiling in Transplantation and Beyond. [PDF]
Galimov N +3 more
europepmc +1 more source
Human CD8+ T-regulatory cells with low-avidity T-cell receptor specific for minor histocompatibility antigens. [PDF]
Burlingham WJ, Goulmy E.
europepmc +1 more source
Identification of a persistent Ascaris-derived Kalirin epitope associated with chronic T cell activation in the lung. [PDF]
Wu Y, Versteeg L, Wu MC, Weatherhead JE.
europepmc +1 more source
Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses. [PDF]
Feng X, Hui KM, Younes HM, Brickner AG.
europepmc +1 more source

